By Geoffrey Smith
Investing.com — U.S. stock markets opened mixed on Tuesday after news that the U.S. will suspend the distribution of Johnson & Johnson (NYSE:)’s Covid-19 vaccine wrongfooted the reopening trades that have dominated in recent weeks.
“We are recommending a pause in the use of this vaccine out of an abundance of caution,” the Food and Drug Administration said in a joint statement with the Center for Disease Control and Prevention on Twitter. The move comes after six patients – all of them women aged between 18 and 48, developed blood clots on the brain within two weeks of taking the vaccine. The problem is similar to the one that has dogged AstraZeneca (NASDAQ:)’s Covid-19 drug, although the incidence appears to be lower: the six cases identified compare to over 6.8 million shots of the J&J drug already distributed.
J&J said it will proactively stop the rollout of the drug in Europe. J&J stock fell 2.4%, dragging down popular ‘reopening’-themed stocks such as airlines and cruise operators.
The news overshadowed a slightly higher-than-expected inflation print for March. The CPI rose 2.6% year-on-year as the collapse of oil prices a year ago created a distorted base effect. The monthly rise in prices, at 0.3%, was however also stronger than expected and the biggest such rise since September.
By 9:40 AM ET (1340 GMT), the was down 180 points, or 0.5%, at 33,565 points. The was down 0.1% but the was up 0.8%.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.